The widening spectrum of infectious neurological disease* Three important areas of study reflect the widening range of neurological infections. These are (a) new technologies for pathogenetic studies and diagnosis, (b) the increasing range of neural pathogens and (c) new therapeutic tools.
infectious diseases relied largely on clinical bedside diagnosis and this is still of critical importance in, for example, many childhood infectious diseases such as chickenpox, measles and mumps, all of which have neurological sequelae. The development of modem investigative techniques can now supplement the classical methods of viral and bacterial isolation from body fluids and measurement of antiviral antibodies.
There are numerous problems when attempting to assign a particular virus to a neurological condition. When a virus is isolated from a patient during such an illness it may be the result of a co-existing and unrelated virus infection. The virus may not be isolated from the neurological or other site or there may be chronic asymptomatic secretion of virus. Moreover, serological studies may be misleading in that there may be non-specific polyclonal activation of virus as part of a generalised immune response to infection. There may also be persistent viral antibody levels from a previous infection. Virus isolation or antibody rises may also represent viral reactivation and not a primary infection. Other problems with serological viral diagnosis include: inadequate sensitivity, inadequate specificity (for example, unwanted cross-reactions), the fact that antibody elevations may be transient, as well as practical difficulties with the collection and timing of specimens.' Some of the more important new technologies available for viral and bacterial diagnosis will now be considered.
(i) Molecular analysis of viral (CT) scanning has clarified some aspects of the natural history of tuberculous meningitis. It has shown, for example, that the incidence of tuberculoma of the nervous system is much greater than had previously been thought during the course of tuberculous meningitis and that many of these lesions do not produce symptoms. 26 CT scanning has been particularly useful in the diagnosis and management of patients with neurocysticercosis. A variety ofabnormalities can be identified by CT scanning including parenchymal cysts, hydrocephalus, areas of calcification and vasculitic infarction.27 Studies using contrast enhancement can also provide specialised information which is particularly useful for monitoring therapy. Moreover, the absence of cerebral oedema, as assessed by CT scanning in patients with cerebral malaria, has directly resulted in modification of therapy in that it has obviated the need for dexamethasone therapy in this condition. 28 Magnetic resonance imaging (MRI) has already proved to be of great value in a variety of infectious neurological diseases. It has been particularly useful in detecting demyelinating lesions in HIV encephalitis29 and through its ability to detect white matter lesions with some precision it can also be used for the non-invasive diagnosis of such conditions as progressive multifocal leucoencephalopathy and post-infectious encephalomyelitis.29 A more recent development is single photon emission computerised tomography (SPECT) scanning in which abnormalities of blood flow have been demonstrated in both herpes simplex encephalitis and non-herpetic encephalitis.?' (b) The widening range of neural pathogens Clinicians have recognised for some time that a wide variety of infectious agents can produce neurological disease. However, over the last decade the range of neurotropic viruses and bacteria has appeared to widen. This includes an increasing range of familiar pathogens as well as the recognition of new pathogens.
There are a number of examples of the first category. Immunosuppressive therapy for malignancy and other conditions with cytotoxic and other drugs has been increasingly effective in recent years. Unfortunately, one of the consequences of this increased therapeutic immunosuppression is an increase in the frequency and range of fungal infections (for example, Candidiasis), viral infections (for example, progressive multifocal leucoencephalopathy (PML) due to the JC papovavirus29) and bacterial infections (for example Listeria monocytogenes) in renal transplant patients.
In some cases there has been a change in the host response to familiar organisms which produce opportunistic infections. The increased range of a species within known pathogenic groups causing disease is well illustrated by spirochaetal infections. For example, while the spirochaete Treponema pallidum has been recognised for many years as being the cause of syphilis, the spirochaete Borrelia burgdorferi, which causes Lyme disease, was first recognised in 1975 in Connecticut, United States.3' Lyme disease, which is tick-borne, may well have been around somewhat earlier than this and the apparent increasing incidence of this disease at present is due, at least in part, to the fact that clinicians are actively seeking evidence of B burgdorferi infection where clinically relevant. A variety of neurological symptoms and signs occur in about 15% of cases when the nervous system is involved in the second stage of the disease.32 This includes meningoencephalitis, cranial nerve palsies and radiculopathy. 32 Another relatively recently recognised disease is legionnaires' disease caused by the bacterium Legionella pneumophila, which is also known to produce diverse neurological impairment.33 Interestingly, legionnaires' disease was prevalent as long ago as the 1940s and 1950s, as shown by retrospective studies,3435 and may well have been the actual cause of some cases of so-called "virus pneumonia".
There are many causes of so-called "new" diseases. An environmental change such as the introduction ofa toxin or irradiation may occur and be manifested in a variety of ways. There may also be a change in the host response to familiar pathogens as occurs frequently in immunosuppressed individuals. A further mechanism is through a pathogen "jumping" species as may well have occurred in the case of HIV. Moreover, a pathogen may be identified by a new technology as in the case of legionnaires' disease and PML. A hypothetical possibility is that a pathogen may be externally introduced either from extraterrestrial sources or through genetic engineering. For practical purposes the only genuinely new recent infectious disease is HIV. However, these various possibilities are not mutually exclusive, for example, for a pathogen to "jump" species thereby extending its own specificity there may well have to be a concomitant change in the properties of the virus itself as well as the host response.
Infection with human immunodeficiency virus (HIV) has now reached epidemic proportions and is emerging as the most serious public health problem that infectious disease physicians and others have to deal with. Neurological complications are a very significant feature of HIV infection at all stages ranging from HIV seropositivity through to AIDS-related complex (ARC) and the fullblown AIDS syndrome. These 
